Amount Raised
$11.9 Million
Round Type
Series A
BelfastBiotechnologyHealth CareTherapeuticsInvestors
Description
Re-Vana Therapeutics Ltd, a privately-held specialty drug delivery company developing sustained-release therapeutics for the treatment of vision-threatening ocular diseases, today announced the closure of its Series A round with $11.9 million in funding, an oversubscription of $4 million. The financing was led by Visionary Ventures. Additional investors include ExSight Ventures, InFocus Capital Partners and existing U.K. investors, Qubis Ltd, Co-Fund NI, and TechStart Ventures.
Quick answer
RE-VANA THERAPEUTICS raised $11.9 Million in a Series A round, dated November 30, 2022. Investors: Tech Start Ventures, Co Fund Ni, In Focus Capital Partners, Ex Sight Ventures, Visionary Ventures and Visionary Ventures Leads Financing Round To Support The Development Of Sustained Release Ophthalmic Therapeutics. RE-VANA THERAPEUTICS is based in Belfast, Northern Ireland, United Kingdom.
- How much did RE-VANA THERAPEUTICS raise?
- RE-VANA THERAPEUTICS raised $11.9 Million in a Series A round on November 30, 2022.
- Who invested in RE-VANA THERAPEUTICS?
- Tech Start Ventures, Co Fund Ni, In Focus Capital Partners, Ex Sight Ventures, Visionary Ventures and Visionary Ventures Leads Financing Round To Support The Development Of Sustained Release Ophthalmic Therapeutics are named as investors in this round.
- What does RE-VANA THERAPEUTICS do?
- Re-Vana Therapeutics Ltd, founded in 2016 as a spin-out from Queen's University Belfast, Northern Ireland, is a specialty ocular therapeutic and drug delivery company with headquarters located in Belfast and a..
- Where is RE-VANA THERAPEUTICS based and how big is it?
- RE-VANA THERAPEUTICS is based in Belfast, Northern Ireland, United Kingdom.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as RE-VANA THERAPEUTICS that raised within 45 days of this round, from Fundz verified event records.
- MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
- Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
- Inotrem raised an undisclosed amount (Funding Round) on January 9, 2023.
- Synthekine raised $100M (Series C) on January 6, 2023.
- HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
- Immune-Onc Therapeutics raised an undisclosed amount (Series B) on January 5, 2023.
Who to call at RE-VANA THERAPEUTICS, and when
A new round usually means RE-VANA THERAPEUTICS is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RE-VANA THERAPEUTICS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RE-VANA THERAPEUTICS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RE-VANA THERAPEUTICS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RE-VANA THERAPEUTICS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansRE-VANA THERAPEUTICS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.